Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation [Phase 2]
Phase 2 trial comparing valganciclovir to valacyclovir for viral prophylaxis in kidney transplantation; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen [Phase 4]
Phase 4 clinical trial comparing steroid-free immunosuppression or calcineurin inhibitor minimization after basiliximab induction with a sta…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis [Phase 4]
Phase 4 trial comparing 3g vs 2g mycophenolate mofetil (MMF) with tacrolimus in renal allograft fibrosis progression; completed study.
-
FDA approval · 2021-10-22FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for Cellcept (mycophenolate mofetil hydrochloride) submitted by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation [Phase 4]
A Phase 4 trial comparing Campath-Tacrolimus vs IL2R monoclonal antibody/Tacrolimus/MMF in renal transplantation has completed with posted r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Magnesium Replacement and Hyperglycemia After Kidney Transplantation [Phase 1, Phase 2]
Clinical trial update exploring magnesium replacement and hyperglycemia after kidney transplantation in Phase 1/2.
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Mycophenolate mofetil from Ascend Laboratories, LLC under ANDA 203005, indicating approval of a …
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (CONCORD BIOTECH LIMITED)
FDA approved a supplemental application for a generic version of mycophenolate mofetil from Concord Biotech Limited.
-
FDA approval · 2021-07-28FDA Approved: NULOJIX — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for NULOJIX (belatacept) submitted by E.R. Squibb & Sons, L.L.C., related to its use in kidney trans…
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation [Phase 1, Phase 2]
A phase 1/2 study of ultra-low dose subcutaneous interleukin-2 in kidney transplantation was terminated; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: Regimen Optimization Study [Phase 2]
Phase 2 regimen optimization study in kidney transplantation has completed and posted results.
-
FDA approval · 2021-05-17FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for mycophenolate mofetil (ANDA 090253), allowing continued marketing of the gener…
-
FDA approval · 2021-04-21FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for mycophenolate mofetil from Accord Healthcare Inc., authorizing the generic product's continued m…
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Effect of Privigen Against Graft Loss [Phase 3]
Phase 3 trial evaluating Privigen for prevention of graft loss in kidney transplant recipients has been completed.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Transversus Abdominis Plane Catheter Following Kidney Transplantation [Phase 3]
Phase 3 clinical trial update for a transversus abdominis plane catheter used after kidney transplantation to manage postoperative pain.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial comparing standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipie…
-
FDA approval · 2021-01-15FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for mycophenolate mofetil from Hikma Pharmaceuticals USA Inc., reflecting a labeling update for this…
-
FDA approval · 2021-01-15FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s mycophenolic acid, supporting its continued regulatory status as a gene…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: OPTImization of the Dose of tacroliMUS by Bayesian Prediction [Phase 4]
Phase 4 trial updating optimal tacroliMUS dosing using Bayesian prediction in kidney transplant patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. [Phase 4]
Phase 4 trial comparing sirolimus plus calcineurin inhibitor versus mycophenolate plus calcineurin inhibitor in ABO-incompatible kidney tran…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based [Phase 3]
Phase 3 trial in maintenance kidney transplant recipients after conversion to belatacept (Nulojix) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation [Phase 1, Phase 2]
Phase 1/2 trial comparing AEB071 vs tacrolimus with mycophenolate, basiliximab and steroids for acute rejection prevention in kidney transpl…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients [Phase 1, Phase 2]
Phase 1/2 trial update evaluating AEB071 in combination with tacrolimus (converted to mycophenolic acid after 3 months) for kidney transplan…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Calcineurin Inhibitor Sparing After Kidney Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating strategies to spare calcineurin inhibitors after kidney transplantation to reduce CNI-related side effects.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal [Phase 4]
Phase 4 clinical trial evaluating withdrawal of calcineurin inhibitors in kidney transplant recipients has completed with results posted.